Evidence map›Paper›PMID 31863532›Full record

ArticleEuropean journal of heart failure2020

Association between systolic ejection time and outcomes in heart failure by ejection fraction.

Priyesh A Patel, Andrew P Ambrosy, Matthew Phelan, Fawaz Alenezi, Karen Chiswell, Melissa K Van Dyke, Jennifer Tomfohr, Narimon Honarpour, Eric J Velazquez

Open access · bronzeAbstract read
In one paragraph

Article in European journal of heart failure, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Heart Failure Medical Therapy: A Review for Structural/Interventional Cardiologists.Structural heart : the journal of the Heart Team · 2022
    Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 1 country.

Priyesh A PatelSanger Heart and Vascular Institute, Atrium Health, Charlotte, NC, USA.
Andrew P AmbrosyDepartment of Cardiology, Kaiser Permanente San Francisco Medical Center, San Francisco, CA, USA.
Matthew PhelanDuke Clinical Research Institute, Durham, NC, USA.
Fawaz AleneziDivision of Cardiology, Duke University Medical Center, Durham, NC, USA.
Karen ChiswellDuke Clinical Research Institute, Durham, NC, USA.
Melissa K Van DykeAmgen Inc., Thousand Oaks, CA, USA.
Jennifer TomfohrDivision of Cardiology, Duke University Medical Center, Durham, NC, USA.
Narimon HonarpourAmgen Inc., Thousand Oaks, CA, USA.
Eric J VelazquezSection of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
Amgen (United States) · USClinical Research Institute · USDuke Medical Center · USKaiser Permanente · USLevine Cancer Institute · USYale University · US

Funding

MULTIDISCIPLINARY HEART &VASCULAR DISEASEST32HL007101 · NHLBI · DUKE UNIVERSITY · PI FREEDMAN, NEIL J. · 1985 to 2020
$9.8M
Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
NHLBI NIH HHS L30 HL133930NHLBI NIH HHS T32 HL007101NHLBI NIH HHS T32 HL069749
6 · The paper itself

Abstract

aimsWorsening heart failure (HF) is associated with shorter left ventricular systolic ejection time (SET), but there are limited data describing the relationship between SET and clinical outcomes. Thus, the objective was to describe the association between SET and clinical outcomes in an ambulatory HF population irrespective of ejection fraction (EF). METHODS AND

resultsWe identified ambulatory patients with HF with reduced EF (HFrEF) and HF with preserved EF (HFpEF) who had an outpatient transthoracic echocardiogram performed between August 2008 and July 2010 at a tertiary referral centre. Multivariable logistic regression was used to evaluate the association between SET and 1-year outcomes. A total of 545 HF patients (171 HFrEF, 374 HFpEF) met eligibility criteria. Compared with HFpEF, HFrEF patients were younger [median age 60 years (25th-75th percentiles 50-69) vs. 64 years (25th-75th percentiles 53-74], with fewer females (30% vs. 56%) and a similar percentage of African Americans (36% vs. 35%). Median (25th-75th percentiles) EF with HFrEF was 30% (25-35%) and with HFpEF was 54% (48-58%). Median SET was shorter (280 ms vs. 315 ms, P < 0.001), median pre-ejection period was longer (114 ms vs. 89 ms, P < 0.001), and median relaxation time was shorter (78.7 ms vs. 93.3 ms, P < 0.001) among patients with HFrEF vs. HFpEF. Death or HF hospitalization occurred in 26.9% (n = 46) HFrEF and 11.8% (n = 44) HFpEF patients. After adjustment, longer SET was associated with lower odds of the composite of death or HF hospitalization at 1 year among HFrEF but not HFpEF patients.

conclusionLonger SET is independently associated with improved outcomes among HFrEF patients but not HFpEF patients, supporting a potential role for normalizing SET as a therapeutic strategy with systolic dysfunction.

Indexed as

Heart FailureAgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedPercutaneous Coronary InterventionPrognosisStroke VolumeAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsEjection fractionHeart failureSystolic ejection timeSystolic function

Identifiers

PMID31863532
PMCPMC7493053
OpenAlexW2995221656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.